Results 31 to 40 of about 10,552 (189)
A case of giant sarcomatoid carcinoma ex-pleomorphic adenoma of the parotid gland
Carcinoma ex pleomorphic adenoma is a rare malignant parotid neoplasm arising from primary or recurrent benign pleomorphic adenoma. Histologically, it can be sub-classified by upwards of eight different variations (e.g., myoepithelial carcinoma, salivary
Mehdi Hasnaoui +4 more
doaj +1 more source
SSR4, a TRAP component induced in B cells, governs BAFFR N‐glycosylation via DDOST to sustain NF‐κB signaling, B‐cell differentiation, and TLS maturation. Its loss impairs anti‐tumor immunity, while overexpression improves antibody glycosylation and ADCC, revealing a critical regulator for cancer immunotherapy.
Wei Zhao +15 more
wiley +1 more source
Metastasizing pleomorphic adenoma of parotid gland: Case report
Pleomorphic adenoma is a benign tumor and the most common salivary gland neoplasm. Metastasizing pleomorphic adenoma shares histological characteristics with pleomorphic adenoma but exhibits malignant behavior, including local lymph node involvement and ...
Wan-Hsun Tsai, Bor-Hwang Kang
doaj +1 more source
This review elucidates the crosstalk between Parkinson's disease and colorectal cancer, driven by shared genetics (PRKN, PINK1, DJ‐1) involving oxidative stress, cell cycle regulation, and inflammation. It identifies the gut microbiota—via functional amyloids and short‐chain fatty acids (SCFAs)—as a mechanistic bridge, offering insights for dual ...
Jiacheng Ying +6 more
wiley +1 more source
Pleomorphic adenoma is the most common neoplasm of the salivary gland. It is usually a well-circumscribed and slow-growing benign tumor. In rare instances, benign pleomorphic adenomas may metastasize and spread to distant sites in which case they are ...
Seo Young Choi +3 more
doaj +1 more source
Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona +5 more
wiley +1 more source
Endoscope-assisted transoral excision of a huge parapharyngeal pleomorphic adenoma
Endoscope-assisted transoral excision of a huge parapharyngeal pleomorphic adenoma. The treatment of choice for a parapharyngeal pleomorphic adenoma is total surgical resection.
T.-Y. Chiang, M.-K. Chen
doaj +2 more sources
Pleomorphic adenoma of the cheek: a case presentation
Background Pleomorphic adenoma, also known as a benign mixed tumor, is the most common salivary gland tumor. The parotid gland accounts for 90% of the total, with the minor salivary glands accounting for 10%.
Ahmed S. Abdelhamid +4 more
doaj +1 more source
Pleomorphic Adenoma of the Trachea [PDF]
Pleomorphic adenoma is a common neoplasm of salivary glands, but its occurrence in the trachea is very rare [1] . Tracheal tumors, including tracheal pleomorphic adenoma, often cause obstructive symptoms such as dyspnea and wheezing mimicking asthma, leading to delay in diagnosis [2] .
Shigehisa, Kajikawa +3 more
openaire +2 more sources
Utility of Combining FIESTA‐C and MENSA for Facial Nerve Identification in Parotid Gland Surgery
This study evaluated the role of FIESTA‐C and MENSA in facial nerve identification and tumor localization in parotid gland surgery. The combination of FIESTA‐C and MENSA improved the accuracy of facial nerve identification and tumor localization compared to either sequence alone.
Kento Yumita +6 more
wiley +1 more source

